These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9375827

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C.
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H83-90. PubMed ID: 14684360
    [Abstract] [Full Text] [Related]

  • 11. Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol.
    Padi SS, Chopra K.
    Nephron; 2002 Jan; 92(3):685-92. PubMed ID: 12372956
    [Abstract] [Full Text] [Related]

  • 12. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts.
    Kramer JH, Weglicki WB.
    Free Radic Biol Med; 1996 Jan; 21(6):813-25. PubMed ID: 8902527
    [Abstract] [Full Text] [Related]

  • 13. Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
    Li YC, Ge LS, Yang PL, Tang JF, Lin JF, Chen P, Guan XQ.
    Eur J Pharmacol; 2010 Aug 25; 640(1-3):112-6. PubMed ID: 20457150
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T, van der Does R, Schräder R, Landgraf H, Kober G.
    J Cardiovasc Pharmacol; 1987 Aug 25; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [Abstract] [Full Text] [Related]

  • 16. β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression.
    Xu C, Hu Y, Hou L, Ju J, Li X, Du N, Guan X, Liu Z, Zhang T, Qin W, Shen N, Bilal MU, Lu Y, Zhang Y, Shan H.
    J Mol Cell Cardiol; 2014 Oct 25; 75():111-21. PubMed ID: 25066695
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of carvedilol on atrioventricular conduction in the ischemic heart.
    Horio T, Ito S, Aoyama M, Takeda Y, Suzumura H, Nakata K, Yamada Y, Suzuki S, Fukutomi T, Itoh M.
    Eur J Pharmacol; 2001 Jan 26; 412(2):145-53. PubMed ID: 11165226
    [Abstract] [Full Text] [Related]

  • 19. Antioxidant enzyme gene expression in rats with remnant kidney induced chronic renal failure.
    Van Den Branden C, Ceyssens B, De Craemer D, De Bleser P, Hellemans K, Geerts A, Verbeelen D.
    Exp Nephrol; 2000 Jan 26; 8(2):91-6. PubMed ID: 10729748
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.